Successful prenatal therapy of anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model

Successful prenatal therapy of anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model

Current research have demonstrated that maternal anti-CD36 antibodies signify a frequent explanation for fetal/neonatal alloimmune thrombocytopenia (FNAIT) in Asian and African populations. Nonetheless, little is understood in regards to the pathomechanism and antenatal remedy of anti-CD36-mediated FNAIT. Right here, we established a novel animal mannequin to look at the medical options of pups from immunized…

Read More